Rankings
▼
Calendar
MESO Q2 2016 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
-$4M
-102.2% margin
Operating Income
-$22M
-542.9% margin
Net Income
-$22M
-556.2% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
-46.6%
Balance Sheet
Total Assets
$791M
Total Liabilities
$298M
Stockholders' Equity
$493M
Cash & Equivalents
$8M
← FY 2016
All Quarters
Q3 2016 →